
| Biological Activity | |||||||||||||||||||||||||
| Synonyms | Isobutylmethylxanthine, 1-Methyl-3-Isobutylxanthine | ||||||||||||||||||||||||
| Chemical Name | 1-Methyl-3-(2-methylpropyl)-7H-purine-2,6-dione | ||||||||||||||||||||||||
| Application | IBMX is a potent and nonspecific inhibitor of PDE (phosphodiesterases) and can increase intracellular cyclic AMP levels | ||||||||||||||||||||||||
| CAS Number | 28822-58-4 | ||||||||||||||||||||||||
| Purity | ≥99.0% | ||||||||||||||||||||||||
| Molecular Weight | 222.24 | ||||||||||||||||||||||||
| Molecular Formula | C₁₀H₁₄N₄O₂ | ||||||||||||||||||||||||
| SMILES | O=C(N1C)N(CC(C)C)C2=C(N=CN2)C1=O | ||||||||||||||||||||||||
| Target & IC50 | PDE3: IC50 = 18 μM PDE4: IC50 = 13 μM PDE1: IC50 = 19 μM PDE5 : IC50 = 32 μM |
||||||||||||||||||||||||
| Shipping | Room Temperature | ||||||||||||||||||||||||
| Storage | Room Temperature | ||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| Solubility | |
| DMSO: 44 mg/mL (197.98 mM) Ethanol: 7 mg/mL (31.50 mM) |
| Product Description | |
IBMX is one of the most potent and nonspecific inhibitors of cyclic nucleotide PDE (phosphodiesterases) with documented IC50 values for PDE1, 2, 3, 4, and 5 equaling 19, 50, 18, 13 and 32. IBMX is documented to raise intracellular cyclic AMP levels. In rat sensory neurons the addition of IBMX caused the release of Ca2+ from caffeine ryanodine sensitive internal stores increasing the internal Ca2+ levels and inducing a biphasic membrane current response. Through PDE inhibition IBMX has also inhibited TNFα. IBMX in breast cancer cells has also induced p21 and p27 through a PKA independent pathway. Although a nonspecific PDE inhibitor IBMX does not show inhibition of PDE8B. |